Award
Delivery Order #SPE2DR26F9WF8
Delivery Order for Ondansetron Tablets Under Long-Term Pharmaceutical Contract
Buyer
Defense Logistics Agency
Award Amount
$17,670.71
Ceiling
$17,670.71
Awarded
March 16, 2026
Period of Performance
Mar 16, 2026 – Mar 17, 2026
Identifier
SPE2DR26F9WF8
NAICS
424210
This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading pharmaceutical distribution company, under the umbrella of an existing long-term indefinite delivery vehicle contract. The contract specifically pertains to the procurement of Ondansetron HCL 4 mg tablets, a medication commonly used to prevent nausea and vomiting in healthcare settings. The significance of this award lies in its support for critical medication supply, ensuring timely availability for patient care. The scope of work covers the delivery of specified quantities of this pharmaceutical product to a designated location in Conshohocken, Pennsylvania. This delivery order follows a competitive procurement process structured within the larger indefinite delivery contract, allowing for flexible and continuous acquisition of necessary pharmaceuticals. The contract is set for a brief performance period, emphasizing prompt fulfillment. The original solicitation is part of a broader program to enhance pharmaceutical product distribution, with AmerisourceBergen's ongoing performance reinforcing the agency's capacity to maintain an efficient healthcare supply chain.
Description
4571167372!ONDANSETRON HCL 4 MG TABLET 500S